Wuhan Jianmin Pharmaceutical Group

Wuhan Jianmin Pharmaceutical Group

Wuhan Jianmin Pharmaceutical engages in the research and development, production, and sale of pharmaceuticals primarily in China.

Launch date
Employees
Market cap
€779m
Enterprise valuation
€701m (Public information from Sep 2024)
Wuhan Hubei (HQ)
Authorizing premium user...